Oncopeptides AB(SE:ONCO)
kr 1.64-0.05 (-3.02%)
SE:ONCO
Oncopeptides AB Revenue
kr 1.64
At close:-0.05 (-3.02%)
Want to see SE:ONCO full AI Analyst Report?
Oncopeptides AB (ONCO) Revenue
11 Followers
Oncopeptides AB Revenue
Oncopeptides AB had a revenue of 28.45M in the quarter ending Sep 30, 2026, with -8.51%. This bring the company's revenue in the last twelve months to 103.50M, Increased 8.65%. In the fiscal year ending Dec 31, 2025, Oncopeptides AB had annual revenue of 71.12M with 124.72% growth.
- Revenue (ttm)
- 103.50M
- Revenue Growth
- 65.37%
- P/S Ratio
- 10.26
- Revenue/Employee
- SEK 1,001,662
- Employees
- 71
- Market Cap
- SEK 729.43M
Revenue Chart
Oncopeptides AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.12M | 39.47M | 124.72% |
| Dec 31, 2024 | 31.65M | -3.57M | -10.14% |
| Dec 31, 2023 | 35.22M | 26.86M | 321.54% |
| Dec 31, 2022 | 8.36M | -109.94M | -92.94% |
| Dec 31, 2021 | 118.30M | 118.30M | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

